About Pentium Capital Partners
Pentium Capital Partners is a venture capital fund that invests in early-stage companies seeking to improve the Planet, its People, and our shared Prosperity. This means we invest in courageous founders with disruptive ideas who join us in our mission to improve the Planet, its People, and our shared Prosperity.
We value deep, meaningful relationships above all else and are in constant pursuit of strategic, meaningful business relationships.
ESG is the path forward
Major banks, finance institutions, and governments, with nearly $130T already committed, have pledged to limit financial support to asset classes and companies that support ESG initiatives. This represents one of the most iconic global efforts to come together to improve the Planet, its People, and our shared Prosperity on a global scale. We want to add to that energy by providing more funding and opportunities to expand the global ESG ecosystem.
ESG funds are more than doubling from the prior year.
Global governments are pledging capital and resources to funds and founders to support their climate initiatives. This adds further momentum to ESG funds and founders; thereby, growing the industry further.
ESG funds could get a further boost if the administration seeks to make it easier for businesses to offer sustainable funds to employees in 401(k) and other workplace retirement plans.
General Partners
Ryan Miller, CEO & Managing General Partner
Ryan is a Venture Capital & Angel investor in technology, placement growth of 5200% ROI in 6 years. Founder & Managing Director at Pentium Capital Advisory Inc. Specializing in Financial Consulting and VC syndication. Chief Financial Officer a National, award-winning InsurTech company. Managed and mentored approx. 200 professionals while serving in this role. Mentored over 200 emerging fund managers to start and scale their investment funds, totaling around $4B in funds raised to date. Managed $250M Technology Portfolio BSc. & Master of Financial Management.
Kam Jones, General Partner
Kameron founded PMO in 2005 after recognizing a need across all industries for world-class technical HSE consulting. Kameron has extensive knowledge, skills, and experience as a business leader in the discipline of Regulatory, Health, Safety, and Environment as well as project and business management. Kameron has acted as a Director and Vice President for major energy producers in Canada and internationally. He is an experienced leader who excels at achieving business objectives in small and large-scale corporate environments.
Advisory Board
Affy Hannan
Affy has been working in energy efficiency, AI and IoT in Australia. Affy saw the opportunity to co-found Okra 5 years ago - using advanced technologies to bring affordable energy access to the 800 Million people without power. He has since built a world class team, making partnerships with key institutions and utility partners and spearheaded Okra’s growth to key South East Asian markets and most recently into Nigeria. Winning multiple awards including being selected as the Representative for Clean Energy Access Startups at the World Economic Forum Champions of Tomorrow and Forbes 30 Under 30 Asia entrepreneur. He’s always on the lookout for new change makers to join the mission of shaping a world of equal opportunity enabled via tech.
Dana Lambert, RPh, PhD
Dana Lambert is an entrepreneur with a passion for creating better medicines. Dr. Lambert holds a diverse background in healthcare management, pharmaceutical research, and capital growth funds based in North American public equities & derivatives. She received a PhD from the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) with a focus on cannabinoid pharmacology, chronic pain pathophysiology and drug formulation. She is an inventor of several patent-pending biopharmaceutical technologies, including those held within the Andira Pharmaceuticals IP portfolio. Dr. Lambert is the recipient of several research awards including the Ruth & Paul Bass Scholarship in Pharmacology and the Kam Li Ma Scholarship in Pharmaceutical Sciences. She has authored several peer reviewed scientific publications, including a primary chronic pain study (Lambert et al., J Neurosci Neuropharm 2018). From 2014 – 2019 she served as a UBC Instructor of pharmaceutical formulation and drug delivery systems in the Doctor of Pharmacy (PharmD) and Undergraduate Pharmacy (B.Sc.Pharm) Programs in the Faculty of Pharmaceutical Sciences. She previously graduated with a B.Sc.(Pharm) from UBC, practiced clinically as a hospital pharmacist (RPh) and managed clinical research programs and quality & safety initiatives for Provincial Health Authorities in British Columbia, Canada. Dr. Lambert currently serves on the Board of Directors for healthcare and financial firms in Canada and the US.
Eric Chalmers, PhD, PEng
Eric has degrees in electrical engineering and biomedical engineering, and over 10 years experience in machine learning, artificial intelligence, and data science. He has worked with brilliant teams to execute projects ranging from theoretical research, to R&D, to deployment of intelligent systems. His work spans domains including health care, agriculture, insurance, medical devices, sports, and more.